找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomarkers for Preclinical Alzheimer’s Disease; Robert Perneczky Book 2018 Springer Science+Business Media, LLC 2018 Epidemiology.imaging.

[復(fù)制鏈接]
查看: 33897|回復(fù): 56
樓主
發(fā)表于 2025-3-21 18:11:25 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease
影響因子2023Robert Perneczky
視頻videohttp://file.papertrans.cn/188/187800/187800.mp4
發(fā)行地址Includes cutting-edge methods and protocols.Provides step-by-step detail essential for reproducible results.Contains key notes and implementation advice from the experts
學(xué)科分類(lèi)Neuromethods
圖書(shū)封面Titlebook: Biomarkers for Preclinical Alzheimer’s Disease;  Robert Perneczky Book 2018 Springer Science+Business Media, LLC 2018 Epidemiology.imaging.
影響因子.This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer’s disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In .Neuromethods. series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory..Comprehensive and cutting-edge, .Biomarkers for Preclinical Alzheimer’s Disease. is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry.”.
Pindex Book 2018
The information of publication is updating

書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease影響因子(影響力)




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease被引頻次




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease被引頻次學(xué)科排名




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease年度引用




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease年度引用學(xué)科排名




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease讀者反饋




書(shū)目名稱(chēng)Biomarkers for Preclinical Alzheimer’s Disease讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:24:51 | 只看該作者
Epidemiology and Risk Factors of Alzheimer’s Disease: A Focus on Dietetween two antagonist pathways: an accumulation of lesions in the brain (evolving progressively over decades), balanced by a variety of cellular and tissular compensatory mechanisms. Preclinical research has indicated that several nutritional factors have the potential to modulate many components of
板凳
發(fā)表于 2025-3-22 03:19:17 | 只看該作者
地板
發(fā)表于 2025-3-22 05:48:59 | 只看該作者
Deriving and Testing the Validity of Cognitive Reserve Candidates to some version of CR as a collection of subject factors that influence cognitive performance beyond simple brain structural health. We give a simple but precise analytic recipe to test requirements for any plausible cognitive reserve candidate based on brain imaging. Gradations of partial fulfillm
5#
發(fā)表于 2025-3-22 09:42:13 | 只看該作者
Methods for Pathological Classification of Alzheimer’s Diseaseil threads consisting of hyperphosphorylated tau, extracellular parenchymal amyloid β plaques, and neuritic plaques. In this chapter, we describe the neuropathological criteria for the neuropathological diagnosis of Alzheimer’s disease, as well as the fixation, processing, and histology protocols re
6#
發(fā)表于 2025-3-22 16:15:30 | 只看該作者
7#
發(fā)表于 2025-3-22 17:42:30 | 只看該作者
Brain Structural Imaging in Alzheimer’s Diseasele, in particular at early stages of the disease progress, and thus not evident by visual inspection alone in magnetic resonance imaging. Group-level statistical comparisons have dominated neuroimaging studies for many years, leading to better insight into the patterns of regional vulnerability in b
8#
發(fā)表于 2025-3-23 00:21:28 | 只看該作者
9#
發(fā)表于 2025-3-23 04:15:16 | 只看該作者
10#
發(fā)表于 2025-3-23 06:24:14 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 21:57
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
尼玛县| 南平市| 石楼县| 平塘县| 柳州市| 安龙县| 义乌市| 嘉禾县| 竹北市| 海口市| 常宁市| 丘北县| 即墨市| 卢龙县| 澄江县| 崇义县| 漾濞| 正安县| 林州市| 娄烦县| 英德市| 昌平区| 许昌县| 稻城县| 阳曲县| 磴口县| 唐海县| 嘉祥县| 平罗县| 光山县| 芦溪县| 江津市| 扎赉特旗| 北流市| 台东市| 金门县| 苍南县| 福建省| 莱西市| 苏州市| 栾川县|